Category: News

This year, 15 undergraduate students from across Canada have been accepted into BioCanRx’s Summer Studentship Program. The program’s goal is to inspire the next generation of highly qualified personnel. Funding is provided to its network investigators to recruit talented university and college students to work on their cancer immunotherapeutic research projects. This opportunity provides students… Read more »

What is the Cancer Stakeholder Alliance?   The BioCanRx Cancer Stakeholder Alliance (CSA) is an open consortium of charities and non-government organizations from across Canada. The organizations represent a variety of cancer indications and are focused on cancer research, advocacy, and support for patients and their families.   With the experience and perspective of cancer… Read more »

By: Kitchissippi Times   Medical professionals sometimes refer to the “pillars” of cancer treatment. Until recently there have been four pillars: surgery, radiotherapy, traditional chemotherapy, and precision therapy. For thousands of years, surgery was the only pillar supporting cancer care. Radiotherapy, or radiation therapy, which uses high-energy particles to destroy cancer cells became a second… Read more »

By: NCE   More than 50 Canadians with lung cancer could be the first trial participants who may benefit from a promising new combination therapy with the potential to significantly improve treatment outcomes, and cause fewer side effects than many current treatments.     Sponsored by Turnstone Biologics, with funding support from BioCanRx (Biotherapeutics for… Read more »

By: Andrew Duffy, Ottawa Citizen   The Ottawa Hospital has launched a new clinical trial that seeks to deploy the combined power of two viruses and an immunotherapy drug to supercharge the body’s immune system — and unleash it against advanced lung cancer.   The trial is being funded largely by a private Ottawa biotech… Read more »

Doctors in Ottawa, Hamilton, seeking 55 lung cancer patients for clinical trial By: Giacomo Panico, CBC News   An experimental treatment that involves injecting a virus into the bloodstream of lung cancer patients has begun clinical trials at hospitals in Ottawa and Hamilton.   It’s hoped the virus will infect cancer cells, and while that… Read more »

Call for Applications             Overview   This program seeks to increase the working journalistic knowledge of cancer immunotherapies, their science and the trajectories of their development in Canada.   It will provide an opportunity for one experienced journalist and one Masters of Journalism student (or recent graduates, hereafter called student)… Read more »

By: John Bell   It’s been nearly 50 years since U.S. President Richard Nixon declared war on cancer. Since then, some battles have been won, others lost. But the traditional weaponry – chemotherapy and radiation – while refined and improved, is still carrying the brunt of battle duty.   In recent years, these two warhorses… Read more »

New funding will help bring the therapy one step closer to clinical use   By: Shelby Soke   David Evans aims to use an oncolytic virus he developed as a treatment for non-muscle invasive bladder cancer. Viruses are commonly associated with illness. Whether it is a nasty stomach bug or a bout of influenza, most… Read more »

By: Heather Blumenthal   It’s one thing to be known among your friends for your famous boeuf bourguignon recipe. It’s another thing entirely to open your own restaurant based on that recipe. All of a sudden you need to deal with things like quality of ingredients, scaling up that favourite recipe to serve multiple times… Read more »